Panel Discussion | How Should We Proceed with Tricuspid Valve Interventions and When Should We Intervene?

Saturday, March 8, 2025

4:34 PM – 5:00 PM ET

Panel Moderator(s)

Azeem Latib, MD

Director, Interventional Cardiology & Structural Heart Interventions
Montefiore Medical Center
Scarsdale, New York, United States

Disclosure(s): Boston Scientific, Metronic: Consulting Fees (e.g., advisory boards) (Ongoing)
Molly Szerlip, MD

Associate Medical Director, Education & Reserach and Regional Director, Sturctural Heart Progam
Baylor Scott and White The Heart Hospital Baylor Plano
Richardson, Texas, United States

Disclosure(s): Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Board (Ongoing); Cardiovascular Innovations Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panel Discussant(s)

Saif Anwaruddin, MD

Associate Prof of Medicine/Director, Structural Heart Program
Medical College Of Wisconsin
Wauwatosa, Wisconsin, United States

Disclosure(s): East End Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Suzanne Arnold, MD

Professor
Saint Luke's Mid America Heart Institute

Disclosure(s): No financial relationships to disclose
Steven F. Bolling, MD

Professor of Cardiac Surgery
University of Michigan Hospital
Ann Arbor, Michigan, United States

Disclosure(s): Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
David J. Cohen, MD, FSCAI

Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)
Abdallah El Sabbagh, MD

Interventional Cardiologist
Mayo Clinic
Jacksonville, Florida, United States

Disclosure(s): No financial relationships to disclose
Raj Makkar, MD, FSCAI, FACC

Vice President of Cardiovascular Innovation and Intervention
Cedars-Sinai Medical Center
Los Angeles, California, United States

Disclosure(s): Abbott: Grant/Research Support (Ongoing); Cedars-Sinai Medical Center: Employee (Ongoing); Cordis: Consultant (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing)
Paul Sorajja, MD

Director, Center for Valve and Structural Heart Disease, Minneapolis Heart Institute, Abbott Northwestern Hospital
Allina Health Minneapolis Heart Institute
Minneapolis, Minnesota, United States

Disclosure(s): LAZA: Consulting Fees (e.g., advisory boards) (Ongoing)
Hendrik Treede, MD

Director
University Heart and Vascular Center Mainz
Mainz, Rheinland-Pfalz, Germany

Disclosure(s): Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Pradeep Yadav, MD

Director of Structural Interventions
Piedmont Atlanta Hospital
Atlanta, Georgia, United States

Disclosure(s): Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)

Disclosure(s):

Azeem Latib, MD: Boston Scientific, Metronic: Consulting Fees (e.g., advisory boards) (Ongoing)

Molly Szerlip, MD: Abbott Vascular, Edwards, Medtronic, Boston Scientific: Advisory Board (Ongoing); Cardiovascular Innovations Foundation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Committee Member), JAMA Cardiology Associate Editor; Faculty CRF: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Saif Anwaruddin, MD: East End Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Suzanne Arnold, MD: No financial relationships to disclose

Steven F. Bolling, MD: Tangent: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); xDOT: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

David J. Cohen, MD, FSCAI: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)

Abdallah El Sabbagh, MD: No financial relationships to disclose

Raj Makkar, MD, FSCAI, FACC: Abbott: Grant/Research Support (Ongoing); Cedars-Sinai Medical Center: Employee (Ongoing); Cordis: Consultant (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); Medtronic: Consultant (Ongoing)

Rishi Puri, MBBS PhD FRACP: No financial relationships to disclose

Paul Sorajja, MD: LAZA: Consulting Fees (e.g., advisory boards) (Ongoing)

Hendrik Treede, MD: Edwards Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); JenaValve Technology Inc.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); medtronic.: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TriCares: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)

Pradeep Yadav, MD: Abbott Labs: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); BSCI: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); DASI Simulations: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edward Lifesciences: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Excision Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); medtronic.: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing); Trisol: Consulting Fees (e.g., advisory boards) (Ongoing)